Among the 80%–90% HER2-negative breast cancers, a low to moderate expression of HER2 (IHC1+ or IHC2+/ISH-negative) still exists and such tumors are identified as HER2-low tumors (8). The gene discussed is ERBB2; the disease is breast carcinoma.